What is the Full Form of IEC in Medical?
The Full Form of IEC in Medical is the Immune Effector Cells. Human body cells known as immune effector cells have the ability to trigger or strengthen an immune response. A wide variety of immune cells known as IECs are able to influence both malignant and non-malignant disease states. As IECs become more widely used as both commercially accessible and investigational treatments, healthcare facilities must create procedures and workflows to administer transformative therapy safely. The range of targets, illnesses, sources, and distinct reactions that a patient may encounter after receiving IEC therapy further complicates this treatment.
To neutralize threats, immune effector cells employ a variety of mechanisms:
- Pathogen engulfment and digestion by neutrophils and macrophages.
- NK along with cytotoxic T cells release cytotoxic granules to destroy diseased or aberrant cells.
- Release of cytokines, which are signalling molecules that control inflammation and draw more immune cells to the infection site.
- Antibodies produced by B cells kill pathogens and identify them so that other immune cells can destroy them.
Use of IEC in therapies:
Immune effector cells play a key role in cancer immunotherapy strategies including NK cell-based treatments, which use the innate cytotoxic properties of NK cells to combat tumors, and CAR T-cell therapy, in which T cells have been modified genetically to target cancer cells. Furthermore, these cells are essential in immunological dysregulated disorders such as autoimmune illnesses, graft-versus-host disease, and persistent infections.